NFATC1 and B-cell chronic lymphocytic leukemia: Constitutive phosphorylation of ERK1/2 in the absence of AKT activation, constitutive phosphorylation of MEK1/2 and NFAT2 overexpression were described to be associated with attenuated BCR signalling upon αIgM treatment in a subset of human CLL patients11.